Executive record

Teri Lawver

Director at Altimmune, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:teri-lawverVersion: public-0As of: 2026-09-28

Not yet claimed9 published Claims3 sources
  • Director

Key Claims

Biography

Teri Lawver currently serves as Chief Commercial Officer at Celldex. She previously served as Executive Vice President and Chief Commercial Officer at Dexcom from January 2023 to November 2024, leading global commercial strategy and operations. Prior to Dexcom, she held various leadership roles at Johnson & Johnson from 2002 to 2022, including Worldwide Vice President of Immunology and Global Vice President of Cardiovascular & Metabolism.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: Chief Commercial Officer · Organization not publishedALT DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ALT DEF 14A director slate

    sec filing · Source published: Mar 17, 2026 · Retrieved: May 15, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Nominating/Governance · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Celldex · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Commercial Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Mar 17, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at Altimmune, Inc. · Claim reviewed: May 15, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Altimmune, Inc. · Claim reviewed: May 15, 2026